Prostate Cancer Clinical Trials in Hershey, Pennsylvania

5 studies are recruiting for prostate cancer in Hershey, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

   The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen deprivation therapy (ADT) regimen by assessment of metastases-free survival in participants with high-risk and very high-risk localised/locally adv…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, Hershey, Pennsylvania

   Locations

   346 in total

   Run by

   AstraZeneca

   See if you can join NCT06952803 on ClinicalTrials.gov

2. Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

   This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in patients with a history of prostate cancer or low-risk disease under active surveillance. The study will determine the recommended Phase II dose (RP2D) and assess the efficacy of INM176 in s…

   Stage

   Phase 1

   Ages

   40 and older

   Site

   Penn State Cancer Institute, Hershey, Pennsylvania

   Run by

   Milton S. Hershey Medical Center

   See if you can join NCT06600698 on ClinicalTrials.gov

3. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

   This study is a first-in-human, Phase 1, open-label, multicenter study to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate cancer (mCRPC).

   Stage

   Phase 1

   Ages

   18 to 100

   Site

   Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania

   Locations

   36 in total

   Run by

   Janux Therapeutics

   See if you can join NCT05519449 on ClinicalTrials.gov

4. Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

   The MRI-targeted biopsy for prostate cancer detection can be performed using one of two techniques: 1. Software-based fusion of MRI and ultrasound images (software fusion) or 2. Visually estimated MRI-informed (cognitive fusion) technique To date, there is a lack of adequately powered RCTs directly…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Pennsylvania State University, Hershey, Pennsylvania

   Locations

   4 in total

   Run by

   Albany Medical College

   See if you can join NCT06517901 on ClinicalTrials.gov

5. Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

   Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in > 90% of cases. However, at th…

   Stage

   Phase 4

   Ages

   18 to 80

   Site

   Penn State-Hershey Medical Center, Hershey, Pennsylvania

   Locations

   3 in total

   Run by

   Albany Medical College

   See if you can join NCT05629494 on ClinicalTrials.gov